052670 — Cheil Bio Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro Cap

Annual cashflow statement for Cheil Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	994	-712	-1,708	-1,446	-417
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	1,852	2,275	568	-557	-601
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-5,507	-2,147	8,606	-2,251	375
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-2,297	-104	7,729	-4,072	-456
Capital Expenditures	-13.9	-65	-11.5	-214	-46.9
Purchase of Fixed Assets
Other Investing Cash Flow Items	4,628	-7,715	6,897	-1,569	2,024
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	4,614	-7,780	6,885	-1,783	1,977
Financing Cash Flow Items	—	—	-40	0	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	6,382	-41.8	-3,083	-39.9	-336
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	8,491	-7,890	11,515	-5,896	1,185